Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 6 39-6, 1999, Pages

  Ghigo, E ^a   Aimaretti, G ^a   Maccario, M ^a   Fanciulli, G ^b   Arvat, E ^a   Minuto, F ^c   Giordano, G ^c   Delitala, G ^b   Camanni, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Insulin like growth factor binding protein 3; Insulin like growth factor I; Insulin like growth factor I generation test; Recombinant human growth hormone

Indexed keywords

GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; LIOTHYRONINE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROXINE;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033002079     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.6.e1009     Document Type: Article

References (30)

1. Amato, G., G. Izzo, I. Salzano, and A. Bellastella. Recombinant human growth hormone (rhGH) treatment at low doses does not significantly change thyroid function in growth hormone deficient adults (GHDA). J. Endocrinol. Invest. 8: 563-566, 1996.
2. Baumann, G., M. A. Shaw, and K. Amburn. Circulating growth hormone binding proteins. J. Endocrinol. Invest. 17: 67-81, 1996.
3. Bengtsson, B.-A. Growth hormone deficiency in adults: a new indication for recombinant human growth hormone. J. Int. Med. Res. 239: 283-286, 1996.
4. Blum, W. F., K. Albertsson-Wikland, S. Rosberg, and M. B. Ranke. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 (IGFBP-3) reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab. 76: 1610-1616, 1993.
5. Blum, W. F., A. M. Cotterill, M. C. Postel-Vinay, M. B. Ranke, M. O. Savage, and P. Wilton. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Pediatr. Suppl. 399: 117-124, 1994.
6. Blum, W. F., and M. B. Ranke. Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. Horm. Res. 33, Suppl. 4: 31-37, 1990.
7. Blum, W. F., M. B. Ranke, K. Kietzmann, E. Gaugge, H. J. Zeisel, and J. R. Bierich. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J. Clin. Endocrinol. Metab. 70: 1292-1298, 1990.
8. Blum, W. F., M. B. Ranke, M. O. Savage, and K. Hall. Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestion for new diagnostic criteria. The Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Pediatr. Suppl. 383: 125-126, 1992.
9. Burman, P., A. G. Johansson, A. Siegbahn, B. Vessby, and F. A. Karlsson. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women (Abstract). J. Clin. Endocrinol. Metab. 82: 555, 1997.
10. Clemmons, D. R., and J. J. Van Wyk. Factors controlling blood concentration of somatomedin C. J. Clin. Endocrinol. Metab. 13: 113-118, 1984.
11. Copeland, K. C., L. E. Underwood, and J. J. Van Wyk. Induction of immunoreactive somatomedin C in human serum by growth hormone: dose-response relationship an effect on chromatographic profiles. J. Clin. Endocrinol. Metab. 50: 690-697, 1980.
12. Corpas, E., S. M. Hartman, and S. Blackman. Human growth hormone and human aging. Endocr. Rev. 14: 20-39, 1993.
13. Cotterill, A. M., C. Camacho-Hubner, K. Woods, C. Martinelli, P. Duquesnoy, and M. O. Savage. The insulin-like growth factor I generation test in the investigation of short stature. Acta Pediatr. Suppl. 399: 128-130, 1994.
14. De Boer, H., G.-J. Blok, C. Popp-Snjders, L. Stuurman, R. C. Baxter, and E. Van der Veen. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum marker. J. Clin. Endocrinol. Metab. 81: 1372-1377, 1996.
15. De Boer, H., G.-J. Blok, and E. A. Van der Veen. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16: 63-86, 1995.
16. Frystyck, J., E. Vestbo, C. Skjaerbaek, C. E. Mogensen, and H. Orskov. Free insulin-like growth factors in human obesity. Metabolism 44: 37-44, 1995.
17. Gatford, K. L., A. R. Egan, I. J. Clark, and P. C. Owens. Sexual dimorphism of the somatotrophic axis. J. Endocrinol. 157: 373-389, 1998.
18. Ghigo, E., G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, and F. Camanni. New approach to the diagnosis of GH deficiency. Eur. J. Endocrinol. 134: 352-356, 1996.
19. Growth Hormone Research Society (GRS). Consensus guidelines for diagnosis and treatment of adults with GH deficiency. Statement of the GRS workshop on adult GHD. J. Clin. Endocrinol. Metab. 83: 379-381, 1998.
20. Ho, K. Y., W. S. Evans, R. M. Blizzard, J. D. Veldhuis, G. R. Merriam, E. Somojlik, R. Furlanetto, A. D. Rogol, D. L. Kaiser, and M. O. Thorner. Effect of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab. 64: 51-58, 1987.
21. Johansson, G., R. Bjarnason, M. Bramnert, L. M. S. Carlsson, M. Degerblad, P. Manhem, T. Rosen, M. Thoren, and B. A. Bengtsson. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age and gender. J. Clin. Endocrinol. Metab. 81: 1575-1581, 1996.
22. Kelly, J., I. A. Rajkovic, A. J. O'Sullivan, C. Sernia, and K. K. Y. Ho. Effects of different oral oestrogen on insulin-like growth factor I, growth hormone binding protein in post menopausal women. Clin. Endocrinol. Metab. 39: 516-517, 1993.
23. Landim-Wilhelmsen, K., L. Wilhelmsen, G. Lappas, T. Rosen, G. Lindsted, P. A. Lundberg, and B. A. Bengtsson. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin. Endocrinol. Metab. 41: 351-356, 1994.
24. Liebermann, S. A., A. M. Mitchell, R. Marcus, R. L. Hintz, and A. R. Hoffman. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm. Metab. Res. 26: 229-233, 1994.
25. Rudman, D., M. H. Kutner, M. A. Goldsmith, J. Kenny, H. Jennings, and R. P. Bain. Further observation on four subgroups of normal variant short stature. J. Clin. Endocrinol. Metab. 51: 1378-1384, 1980.
26. Skjaerbaek, C., J. Frystik, J. Moller, J. S. Christiansen, and H. Orskov. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults. Eur. J. Endocrinol. 135: 672-677, 1996.
27. Thissen, J.-P., J.-M. Ketelslegers, and L. E. Underwood. Nutritional regulation of the insuli-like growth factors. Endocr. Rev. 15: 80-81, 1994.
28. Underwood, L. E., and J. J. Van Wyk. Normal and aberrant growth. In: Williams Textbook of Endocrinology (8th ed.), edited by J. D. Wilson and D. W. Foster. Philadelphia, PA: Saunders, 1992, p. 1079.
29. Veldhuis, J. D. New modalities for understanding dynamic regulation of the somatotropic (GH) axis: explication of gender differences in GH neuroregulation in the human. J. Pediatr. Endocrinol. Metab. 9: 237-253, 1996.
30. Weissberger, A. J., K. K. Y. Ho, and L. Lazarus. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72: 374-381, 1991.